Want to see CDLX full AI Analyst Report?
CDLX Stock Chart & Stats
$1.01
-$0.18(-5.23%)
At close: 4:00 PM EST
$1.01
-$0.18(-5.23%)
Day’s Range― - ―
52-Week Range$3.95 - $32.80
Previous CloseN/A
Volume316.83K
Average Volume (3M)96.19K
Market Cap
$24.16M
Enterprise Value$203.34M
Total Cash (Recent Filing)$59.80M
Total Debt (Recent Filing)$210.03M
Price to Earnings (P/E)―
Beta2.51
Next Earnings
Aug 04, 2026EPS Estimate
-2.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-17.80
Shares Outstanding5,807,863
10 Day Avg. Volume128,117
30 Day Avg. Volume96,187
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-9.39
Price to Sales (P/S)0.26
P/FCF Ratio6.93
Enterprise Value/Market Cap8.42
Enterprise Value/Revenue0.99
Enterprise Value/Gross Profit2.11
Enterprise Value/Ebitda-2.98
Forecast
1Y Price Target
$10.00Price Target Upside890.10% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)-8.77
Revenue Forecast (FY)$152.79M
Bulls Say, Bears Say
Bulls Say
Positive Free Cash FlowRecent conversion to positive operating and free cash flow provides a durable source of internal funding. Sustained FCF reduces reliance on external financing, supports working-capital needs, and creates optionality to invest in product, repay debt, or bridge through revenue recovery periods.
Margin Expansion & Cost CutsMaterial expense reductions and a record adjusted contribution margin show the business can operate with a leaner cost base. If sustained, these structural efficiency gains make breakeven at lower revenue levels more achievable and improve the scalability of ad programs.
AI & Tech Investments Improving ProductProduct and AI improvements shorten data-to-insight cycles and boost engineering productivity. These durable technology advances enhance targeting and measurement, increasing advertiser ROI and stickiness while lowering marginal cost to serve campaigns over time.
Bears Say
Weakened Balance Sheet & LeverageSubstantial debt combined with negative equity materially limits financial flexibility. This capital-structure weakness raises refinancing and covenant risk, constrains growth investments, and increases the likelihood management must prioritize deleveraging or equity actions over product or sales investments.
Sharp Revenue And Billings DeclinesSteep year-over-year declines in core billings and revenue indicate erosion of scale and advertiser demand. Loss of scale undermines network effects, reduces bargaining power with banks and merchants, pressures per-user economics, and makes fixed-cost absorption and sustainable profitability harder to achieve.
Nasdaq Deficiency & Reverse Stock SplitA Nasdaq deficiency and reverse split are structural corporate actions that can impair liquidity, shrink the float, and complicate future capital raises. These measures signal sustained market-pressure and limit tactical flexibility for the company during a multi-quarter recovery.
Cardlytics News
CDLX FAQ
What was Cardlytics, Inc.’s price range in the past 12 months?
Cardlytics, Inc. lowest stock price was $3.95 and its highest was $32.80 in the past 12 months.
What is Cardlytics, Inc.’s market cap?
Cardlytics, Inc.’s market cap is $24.16M.
When is Cardlytics, Inc.’s upcoming earnings report date?
Cardlytics, Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 23 days.
How were Cardlytics, Inc.’s earnings last quarter?
Cardlytics, Inc. released its earnings results on May 07, 2026. The company reported -$0.8 earnings per share for the quarter, beating the consensus estimate of -$3.7 by $2.9.
Is Cardlytics, Inc. overvalued?
According to Wall Street analysts Cardlytics, Inc.’s price is currently Undervalued.
Does Cardlytics, Inc. pay dividends?
Cardlytics, Inc. does not currently pay dividends.
What is Cardlytics, Inc.’s EPS estimate?
Cardlytics, Inc.’s EPS estimate is -2.3.
How many shares outstanding does Cardlytics, Inc. have?
Cardlytics, Inc. has 5,807,863 shares outstanding.
What happened to Cardlytics, Inc.’s price movement after its last earnings report?
Cardlytics, Inc. reported an EPS of -$0.8 in its last earnings report, beating expectations of -$3.7. Following the earnings report the stock price went down -18.161%.
Which hedge fund is a major shareholder of Cardlytics, Inc.?
Currently, no hedge funds are holding shares in CDLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cardlytics, Inc.
Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments. This system allows marketers to engage customers through the vast networks of their financial institution partners, leveraging digital avenues such as online portals, mobile applications, email, and various real-time alerts. Furthermore, the company offers the Bridg platform, a comprehensive customer data solution that processes point-of-sale information. This enables marketers to conduct advanced analytics, implement highly targeted loyalty initiatives, and precisely evaluate the performance of their marketing efforts. Cardlytics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.
CDLX Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: strong execution on cost reductions, margin expansion (60.6% adjusted contribution margin), positive adjusted EBITDA on a continued-operations basis, improved cash-flow trends, robust U.K. growth (+21% YoY) and product/AI progress. However, these operational improvements were offset by significant year-over-year declines in core scale metrics (billings -37%, revenue -39%), a 21.3% drop in ACPU, and the material impact of losing Bank of America as a partner. Management provided sequential-growth guidance for Q2, indicating confidence in recovery, but near-term top-line weakness remains notable.View all CDLX earnings summariesCDLX Revenue Breakdown
94.25% U.S.
5.75% U.K.
CDLX Stock 12 Month Forecast
Average Price Target
$10.00
▲(890.10% Upside)
Technical Analysis
Ownership Overview
12.39% Insiders
6.04% Mutual Funds
27.22% Other Institutional Investors
49.83% Public Companies and
Individual Investors